Brief: Radiopharm Theranostics Ltd Co Partners With Starpharma On Research And Option Agreement To Develop Novel Radiotherapy Asset
30/09/2025 11:17
Sept 30 (Reuters) - Radiopharm Theranostics Ltd RAD.AX: RADIOPHARM THERANOSTICS LTD: CO PARTNERS WITH STARPHARMA ON RESEARCH AND OPTION AGREEMENT TO DEVELOP NOVEL RADIOTHERAPY ASSET Source text: [ID:n0001213900-25-093349] Further company coverage: RAD.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starpharma Holdings
See all newsAustralia's Starpharma hits 3-1/2-year high on FDA nod for cancer-treating therapy
Brief: Radiopharm Theranostics Ltd Co Partners With Starpharma On Research And Option Agreement To Develop Novel Radiotherapy Asset
Australia's Starpharma jumps on plans to develop novel radiotherapy treatment
Brief: Starpharma Holdings Signs Research And Option Agreement With Radiopharm Theranostics
Australia's Starpharma hits over 2-year high on cancer therapy deal